Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action

Neuroscience Letters

Volumn 227, Issue 1, 1997, Pages 1-4

  Warncke, Torhild ^a   Jørum, Ellen ^a   Stubhaug, Audun ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Hyperalgesia; Ketamine; Lidocaine; N Methyl D aspartate receptor antagonist; Peripheral action

Indexed keywords

KETAMINE; LIDOCAINE; N METHYL DEXTRO ASPARTIC ACID;

ADULT; ARTICLE; BURN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; ETIOLOGY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYPERALGESIA; MALE; NOCICEPTION; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; SKIN TEMPERATURE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT INDICATION;

ADULT; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; HYPERALGESIA; KETAMINE; MALE; RECEPTORS, N-METHYL-D-ASPARTATE; SENSORY THRESHOLDS;

EID: 0030998220     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00263-2     Document Type: Article

References (14)

1. Arhem P., Rydquist B. The mechanism of action of ketamine on the myelinated nerve membrane. Eur. J. Pharmacol. 126:1986;245-251.
2. Benoit E., Carratu M.R., Dubois J.M., Mitolo-Chieppa D. Mechanism of action of ketamine in the current and voltage clamped myelinated nerve fibre of the frog. Br. J. Pharmacol. 87:1986;291-297.
3. Carlton S.M., Hargett G.L., Coggeshall R.E. Localization and activation of glutamate receptors in unmyelinated axons of glaborous skin. Neurosci. Lett. 197:1995;25-28.
4. Durrani Z., Winnie A.P., Elemer K.Z., Burnett M.L. Ketamine for intravenous regional anesthesia. Anesth. Analg. 68:1989;323-328.
5. Frenkel C., Urban B.W. Molecular actions of racemic ketamine on human CNS sodium channels. Br. J. Anaesth. 69:1992;292-297.
6. Hardy J.D., Wolff G., Goodell H. Experimental evidence on the nature of cutaneous hyperalgesia. J. Clin. Invest. 29:1950;115-140.
7. Haley J.E., Sullivan A.F., Dickenson A.H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518:1990;218-226.
8. LaMotte R.H., Shain C.N., Simone D.A., Tsai E.F. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J. Neurophysiol. 66:1991;190-211.
9. Raja S.N., Campbell J.N., Meyer R.A. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin. Brain. 107:1984;1179-1188.
10. Shrivastav B.B. Mechanism of ketamine block of nerve conduction. J. Pharmacol. Exp. Ther. 210:1977;162-170.
11. Torebjörk H.E., Lundberg L.E., LaMotte R.H. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J. Physiol. 448:1992;765-780.
12. Warncke, T., Stubhaug, A. and Jørum, E., Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double blind, cross-over comparison with morphine and placebo, Pain, (1997) in press.
13. Woolf C.J., Thompson S.W.N. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activity; implication for the treatment of postinjury pain hypersensitivity states. Pain. 44:1991;293-299.
14. Zhou S., Bonasera L., Carlton S.M. Periheral administration of NMDA, AMPA or KA results in pain behaviors in rats. NeuroReport. 7:1996;895-900.